Fiduciary Trust’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $160K | Hold |
14,074
| – | – | ﹤0.01% | 807 |
|
|
2025
Q1 | $167K | Hold |
14,074
| – | – | ﹤0.01% | 795 |
|
|
2024
Q4 | $265K | Hold |
14,074
| – | – | ﹤0.01% | 602 |
|
|
2024
Q3 | $316K | Hold |
14,074
| – | – | ﹤0.01% | 555 |
|
|
2024
Q2 | $294K | Hold |
14,074
| – | – | ﹤0.01% | 549 |
|
|
2024
Q1 | $207K | Hold |
14,074
| – | – | ﹤0.01% | 620 |
|
|
2023
Q4 | $145K | Hold |
14,074
| – | – | ﹤0.01% | 608 |
|
|
2023
Q3 | $111K | Hold |
14,074
| – | – | ﹤0.01% | 598 |
|
|
2023
Q2 | $141K | Hold |
14,074
| – | – | ﹤0.01% | 612 |
|
|
2023
Q1 | $125K | Hold |
14,074
| – | – | ﹤0.01% | 602 |
|
|
2022
Q4 | $155K | Hold |
14,074
| – | – | ﹤0.01% | 606 |
|
|
2022
Q3 | $183K | Buy |
14,074
+3,357
| +31% | +$43.7K | ﹤0.01% | 590 |
|
|
2022
Q2 | $136K | Hold |
10,717
| – | – | ﹤0.01% | 611 |
|
|
2022
Q1 | $150K | Buy |
10,717
+855
| +9% | +$12K | ﹤0.01% | 649 |
|
|
2021
Q4 | $286K | Buy |
9,862
+3,182
| +48% | +$92.3K | ﹤0.01% | 573 |
|
|
2021
Q3 | $200K | Buy |
+6,680
| New | +$200K | ﹤0.01% | 630 |
|